Parnell Pharmaceuticals Holdings Ltd
OTC:PARNF
Income Statement
Earnings Waterfall
Parnell Pharmaceuticals Holdings Ltd
Income Statement
Parnell Pharmaceuticals Holdings Ltd
| Jun-2015 | Dec-2015 | Jun-2016 | ||
|---|---|---|---|---|
| Revenue | ||||
| Interest Expense |
0
|
1
|
2
|
|
| Revenue |
9
N/A
|
13
+53%
|
16
+25%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(6)
|
(8)
|
(8)
|
|
| Gross Profit |
2
N/A
|
5
+157%
|
8
+51%
|
|
| Operating Income | ||||
| Operating Expenses |
(15)
|
(25)
|
(31)
|
|
| Selling, General & Administrative |
(15)
|
(25)
|
(31)
|
|
| Other Operating Expenses |
0
|
0
|
(0)
|
|
| Operating Income |
(13)
N/A
|
(19)
-53%
|
(23)
-21%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
3
|
(1)
|
(2)
|
|
| Total Other Income |
5
|
7
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(14)
-212%
|
(23)
-69%
|
|
| Net Income | ||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(4)
|
(14)
|
(23)
|
|
| Net Income (Common) |
(4)
N/A
|
(14)
-211%
|
(23)
-69%
|
|
| EPS (Diluted) |
-0.33
N/A
|
-1.03
-212%
|
-1.58
-53%
|
|